TY - JOUR
T1 - Acquired infection during neonatal and pediatric extracorporeal membrane oxygenation
AU - Cashen, Katherine
AU - Reeder, Ron
AU - Dalton, Heidi J.
AU - Berg, Robert A.
AU - Shanley, Thomas P.
AU - Newth, Christopher J.L.
AU - Pollack, Murray M.
AU - Wessel, David
AU - Carcillo, Joseph
AU - Harrison, Rick
AU - Dean, J. Michael
AU - Tamburro, Robert
AU - Meert, Kathleen L.
N1 - Funding Information:
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the following cooperative agreements from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services: U10HD050096, U10HD049981, U10HD049983, U10HD050012, U10HD063108, U10HD063106, U10HD063114, and U01HD049934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funding Information:
The authors wish to acknowledge the contributions of the following CPCCRN principal investigators, research coordinators and data coordinating center staff: Stephanie Bisping, BSN, RN, CCRP, Alecia Peterson, BS and Jeri Burr, MS, RN-BC, CCRC from University of Utah; Mary Ann DiLiberto, BS, RN, CCRC and Carol Ann Twelves, BS, RN from The Children?s Hospital of Philadelphia; Jean Reardon, MA, BSN, RN and Elyse Tomanio, BSN, RN from Children?s National Medical Center; Aimee Labell, MS, RN from Phoenix Children?s Hospital; Margaret Villa, RN and Jeni Kwok, JD from Children?s Hospital Los Angeles; Mary Ann Nyc, BS from UCLA Mattel Children?s Hospital; Ann Pawluszka, BSN, RN and Melanie Lulic, BS from Children?s Hospital of Michigan; Monica S. Weber, RN, BSN, CCRP and Lauren Conlin, BSN, RN, CCRP from University of Michigan; Alan C. Abraham, BA, CCRC from University of Pittsburgh Medical Center; and Tammara Jenkins, MSN, RN from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health. The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the following cooperative agreements from the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services: U10HD050096, U10HD049981, U10HD049983, U10HD050012, U10HD063108, U10HD063106, U10HD063114, and U01HD049934. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© The Author(s) 2018.
PY - 2018/9/1
Y1 - 2018/9/1
N2 - Introduction: Our objectives are to (1) describe the pathogens, site, timing and risk factors for acquired infection during neonatal and pediatric ECMO and (2) explore the association between acquired infection and mortality. Methods: Secondary analysis of prospective data collected by the Collaborative Pediatric Critical Care Research Network between December 2012 and September 2014. Clinical factors associated with acquired infection were assessed with multivariable Cox regression. Factors associated with mortality were assessed with logistic regression. Results: Of 481 patients, 247 (51.3%) were neonates and 400 (83.2%) received venoarterial ECMO. Eighty (16.6%) patients acquired one or more infections during ECMO; 60 (12.5%) patients had bacterial, 21 (4.4%) had fungal and 11 (2.3%) had viral infections. The site of infection included respiratory for 53 (11.0%) patients, bloodstream for 21 (4.4%), urine for 20 (4.2%) and other for 7 (1.5%). Candida species were most common. Median time to infection was 5.2 days (IQR 2.3, 9.6). On multivariable analysis, a greater number of procedures for ECMO cannula placement was independently associated with increased risk of acquired infection during ECMO (Hazard Ratio 2.13 (95% CI 1.22, 3.72), p<0.01) and receiving ECMO in a neonatal ICU compared to a pediatric or cardiac ICU was associated with decreased risk (Hazard Ratio pediatric ICU 4.25 (95% CI 2.20, 8.20), cardiac ICU 2.91 (95% CI 1.48, 5.71), neonatal ICU as reference, p<0.001). Acquired infection was not independently associated with mortality. Conclusion: ECMO procedures and location may contribute to acquired infection risk; however, acquired infection did not predict mortality in this study.
AB - Introduction: Our objectives are to (1) describe the pathogens, site, timing and risk factors for acquired infection during neonatal and pediatric ECMO and (2) explore the association between acquired infection and mortality. Methods: Secondary analysis of prospective data collected by the Collaborative Pediatric Critical Care Research Network between December 2012 and September 2014. Clinical factors associated with acquired infection were assessed with multivariable Cox regression. Factors associated with mortality were assessed with logistic regression. Results: Of 481 patients, 247 (51.3%) were neonates and 400 (83.2%) received venoarterial ECMO. Eighty (16.6%) patients acquired one or more infections during ECMO; 60 (12.5%) patients had bacterial, 21 (4.4%) had fungal and 11 (2.3%) had viral infections. The site of infection included respiratory for 53 (11.0%) patients, bloodstream for 21 (4.4%), urine for 20 (4.2%) and other for 7 (1.5%). Candida species were most common. Median time to infection was 5.2 days (IQR 2.3, 9.6). On multivariable analysis, a greater number of procedures for ECMO cannula placement was independently associated with increased risk of acquired infection during ECMO (Hazard Ratio 2.13 (95% CI 1.22, 3.72), p<0.01) and receiving ECMO in a neonatal ICU compared to a pediatric or cardiac ICU was associated with decreased risk (Hazard Ratio pediatric ICU 4.25 (95% CI 2.20, 8.20), cardiac ICU 2.91 (95% CI 1.48, 5.71), neonatal ICU as reference, p<0.001). Acquired infection was not independently associated with mortality. Conclusion: ECMO procedures and location may contribute to acquired infection risk; however, acquired infection did not predict mortality in this study.
UR - http://www.scopus.com/inward/record.url?scp=85045290353&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85045290353&partnerID=8YFLogxK
U2 - 10.1177/0267659118766436
DO - 10.1177/0267659118766436
M3 - Article
C2 - 29638203
AN - SCOPUS:85045290353
SN - 0267-6591
VL - 33
SP - 472
EP - 482
JO - Perfusion
JF - Perfusion
IS - 6
ER -